Daily as of 3 Nov 16:00 ET
- Price
- above both $250.17 vs 50 $242.19 / 200 $238.49
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 18 Feb 2025 · projected 3 bars out
ASND | Ascendis Pharma A/S Ordinary ShareNASDAQCommon stock golden cross and death cross projections, cross tests and history
$250.17
+$1.19 (+0.48%)
Ascendis Pharma A/S Ordinary Share (ASND) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2018.
The 50 SMA sits above the 200 on the daily, with no cross projected inside the 30 bars Cruxta tracks. Price sits above the 50 and the 200 on the daily, the weekly and the 4-hour.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- above both $251.27 vs 50 $233.19 / 200 $158.68
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross week of 22 Jul 2024 · projected 26 bars out · tested 2 bars
4-hour as of 3 Nov 16:00 ET
- Price
- above both $250.17 vs 50 $235.23 / 200 $247.46
- Projection
- 🟨Golden cross estimated in 17 to 24 bars
- Test
- No active test
- Last cross
- 💀Death cross 5 Oct 2026 · projected 16 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 5 Oct 2026 | 💀Death | 4-hour | 16 bars out | Not tested |
| 2 Jul 2026 | 🟨Golden | 4-hour | 28 bars out | Not tested |
| 15 Jun 2026 | 💀Death | 4-hour | 24 bars out | 5 bar cross test |
| 24 Feb 2025 | 🟨Golden | 4-hour | 17 bars out | — |
| 18 Feb 2025 | 🟨Golden | daily | 3 bars out | Not tested |
About ASND
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$149M
4-hour coverageYes, since Oct 2025
History on recordSince 2018
Cap bandlarge